Related Experiment Video
Updated: Jan 23, 2026

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Platelet Rubicon Bidirectional Regulation of GPVI and Integrin αIIbβ3 Signaling Mitigates Stroke Infarction Without
Xiaoyan Chen1,2, Jingke Li1,2, Yangyang Liu3
1Department of Pathology and Pathophysiology and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Researchers found that the autophagic protein Rubicon is crucial for preventing stroke and brain hemorrhage. Targeting Rubicon
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Platelet receptors glycoprotein VI (GPVI) and integrin αIIbβ3 play critical roles in thrombosis and hemostasis.
- Targeting GPVI is a potential strategy for cerebral ischemia-reperfusion injury (CIRI) therapy, but underlying mechanisms are unclear.
- Autophagy and its regulatory proteins, like Rubicon, are increasingly recognized for their roles in platelet function and vascular diseases.
Purpose of the Study:
- To elucidate the cellular mechanism of Rubicon in platelet function and its role in cerebral ischemia-reperfusion injury (CIRI).
- To investigate the interaction of Rubicon with Bruton's tyrosine kinase (Btk) and its impact on GPVI and αIIbβ3 signaling.
- To evaluate the therapeutic potential of targeting the Rubicon-Btk pathway for CIRI treatment.
Main Methods:
- Generated megakaryocyte-platelet-specific Rubicon-deficient mice.
- Investigated the interaction between Rubicon and Btk using co-immunoprecipitation and other biochemical assays.
- Assessed thrombus formation and stability in vitro and in vivo.
- Evaluated cerebral infarction volume and hemorrhage in mouse models of stroke.
- Measured Rubicon expression in platelets from patients with acute ischemic-reperfusion injury.
Main Results:
- Megakaryocyte-platelet-specific deficiency of Rubicon accelerated stroke and exacerbated cerebral hemorrhage.
- Rubicon interacts with Btk to inhibit GPVI-mediated thrombus formation.
- Rubicon prevents αIIbβ3-mediated selective autophagy and Btk degradation, stabilizing platelet thrombi.
- Rubicon expression is decreased in platelets of patients with acute ischemic-reperfusion injury.
- A peptide mimicking the Rubicon-Btk interaction significantly reduced cerebral infarction volume in mice.
Conclusions:
- Rubicon plays a critical, previously unrecognized role in regulating platelet function and mitigating cerebral ischemia-reperfusion injury.
- The Rubicon-Btk interaction is a key regulator of both GPVI and αIIbβ3 signaling pathways in platelets.
- Rubicon is dispensable for hemostasis but crucial during the reperfusion phase of CIRI.
- Peptide-based therapeutics mimicking Rubicon's function represent a promising, selective, and safe strategy for treating CIRI.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
11:32Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
GTPases and their Regulation
Large G-proteins,...